Notice Number: NOT-AI-09-045

Key Dates
Release Date: June 15, 2009

Issued by
National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov)

Purpose

The purpose of this notice is to announce NIAID’s participation in the following FOAs:

Nanoscience and Nanotechnology in Biology and Medicine (R01) (PA-08-052)
http://grants.nih.gov/grants/guide/pa-files/PA-08-052.html
Nanoscience and Nanotechnology in Biology and Medicine (R21) (PA-08-053)
http://grants.nih.gov/grants/guide/pa-files/PA-08-053.html

The following text includes an introductory statement and a prioritized list of NIAID-wide interests that we seek to have added to the FOAs under:

Section I. Funding Opportunity Description – Research Objectives, Examples of research topics:

The National Institute of Allergy and Infectious Diseases is interested in supporting projects implementing nanoscience and nanotechnology to address the following priorities

• Nanotechnology-based delivery systems for: 
• Chemo-immuno-therapeutics and prevention approaches including vaccines and topical microbicides
• Disease-specific targeting
• Tools and approaches to understand viral, bacterial, and fungal pathogenesis and host cellular immune response to allergens and/or infecting pathogens.
• Bio-imaging applications for disease and treatment evaluation
• Rapid and cost effective platforms forearly and establisheddiseasepathogen detection, resistance evaluation, host response biomarker evaluation, and genetic testing
• Interrogation of the safety of current and proposed nanotechnology platforms and strategies  

Contacts:  [email protected], [email protected]; [email protected]; [email protected]
           
Section VII. Agency Contacts, 1. Scientific/Research Contacts in the following format:

Timothy Gondre-Lewis, [email protected]

Maureen Beanan, [email protected]

Tia Frazier, [email protected]

Peter Kim, [email protected]

Other than the changes noted above, all other aspects of these two FOAs remain unchanged.